GAG
DXCM icon

GM Advisory Group’s DexCom DXCM Stock Holding History

GM Advisory Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,084
Closed -$1.48M – 256
2024
Q2 		$1.48M Buy
13,084
+22
+0.2% +$2.78K 0.1% 91
2024
Q1 		$1.81M Sell
13,062
-174
-1% -$21.9K 0.13% 78
2023
Q4 		$1.64M Buy
13,236
+936
+8% +$95.6K 0.12% 71
2023
Q3 		$1.15M Buy
12,300
+589
+5% +$66.4K 0.09% 72
2023
Q2 		$1.5M Sell
11,711
-1,851
-14% -$224K 0.12% 63
2023
Q1 		$1.58M Sell
13,562
-3,650
-21% -$409K 0.14% 61
2022
Q4 		$1.95M Buy
17,212
+12
+0.1% +$1.32K 0.21% 50
2022
Q3 		$1.39M Sell
17,200
-18,280
-52% -$1.55M 0.17% 60
2022
Q2 		$2.64M Buy
35,480
+14,080
+66% +$1.29M 0.41% 41
2022
Q1 		$2.74M Buy
+21,400
New +$2.34M 0.33% 49

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GM Advisory Group's DXCM Position: Q3 2024 in Review

GM Advisory Group sold out of DexCom (DXCM) in Q3 2024, closing a stake of 13,084 shares — an estimated $1.48M sold.

GM Advisory Group first reported a position in DXCM in Q1 2022 and held it in 10 quarters. The position peaked at $2.74M in Q1 2022. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • GM Advisory Group reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • GM Advisory Group sold 13,084 DexCom shares in Q3 2024, an estimated $1.48M.
  • GM Advisory Group first reported a position in DexCom in Q1 2022 and held it in 10 quarters.
  • GM Advisory Group's DexCom position peaked at $2.74M in Q1 2022.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on GM Advisory Group's 13F filing for Q3 2024, filed 12 Nov 2024.